✦ LIBER ✦

Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia

✍ Scribed by Santos, Paulo Caleb Junior Lima; Morgan, Aline Cruz; Jannes, Cintia Elin; Turolla, Luciana; Krieger, Jose Eduardo; Santos, Raul D.; Pereira, Alexandre Costa

Book ID: 122240941
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 229 KB
Volume: 233
Category: Article
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2013.12.028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Influence of genotype at the low density

Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolaemia

✍ Xi-Ming Sun; Dilip D. Patel; Brian L. Knight; Anne K. Soutar 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 175 KB

The type of mutation in the low density

The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolaemia

✍ Karen E Heath; Vilmundur Gudnason; Steve E Humphries; Mary Seed 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Lipid-lowering response of the HMG-CoA r

Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in Brazilian patients with primary hypercholesterolemia

✍ Luis A. Salazar; Mario H. Hirata; Éder C.R. Quintão; Rosario D.C. Hirata 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB 👁 2 views

Although the efficacy of fluvastatin (HMG-CoA reductase inhibitor) in the treatment of primary hypercholesterolemia is well documented, a wide interindividual variation treatment response has been observed. We have studied the possible role of the AvaII (exon 13), HincII (exon 12), and PvuII (intron

Heterozygous familial hypercholesterolae

Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low-density-lipoprotein receptor gene and PvuII polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment

✍ A. F. VUORIO; J.-P. OJALA; S. SARNA; H. TURTOLA; M. J. TIKKANEN; K. KONTULA 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 472 KB

Effects of simvastatin on the lipid prof

Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial

✍ Andrew J. Lewin; Mark S. Kipnes; Luigi F. Meneghini; Diane J. Plotkin; Inna T. P 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 175 KB